Austerity measures could further shrink French drug market

03/20/2013 | Chicago Tribune (tiered subscription model)

Drug sales in France, Europe's second largest market, are expected to decline more than 3% this year as the government continues to reduce health care spending through price cuts and greater use of generics, according to the pharmaceutical intelligence firm IMS Health. By contrast, other mature markets like the United States, Germany and Japan should register slight increases, and growth rates in Brazil and China may exceed 10%. This is the second consecutive year of declines in France.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC